TABLE 2.
Patient-Reported Outcome Measure Scoresa
| Variable | 1 y | 2 y | P Value |
|---|---|---|---|
| IKDC (0 to 100) | 86.2 ± 10.6 (58.6 to 100.0) | 91.6 ± 8.3 (68.0 to 100.0) | .006 |
| KOS ADL (0 to 80) | 72.8 ± 7.5 (43.0 to 80.0) | 75.1 ± 6.3 (49.0 to 80.0) | .099 |
| KOOS Pain (0 to 100) | 90.7 ± 10.2 (58.3 to 100.0) | 95.1 ± 7.8 (58.3 to 100.0) | .017 |
| KOOS Symptoms (0 to 100) | 87.4 ± 12.3 (50.0 to 100.0) | 92.0 ± 9.9 (57.1 to 100.0) | .046 |
| KOOS ADL (0 to 100) | 96.2 ± 8.5 (50.0 to 100.0) | 96.9 ± 8.5 (50.0 to 100.0) | .679 |
| KOOS Sport/Recreation (0 to 100) | 86.9 ± 14.8 (50.0 to 100.0) | 90.8 ± 12.7 (50.0 to 100.0) | .161 |
| KOOS Quality of Life (0 to 100) | 73.8 ± 19.1 (31.3 to 100.0) | 82.4 ± 17.2 (37.5 to 100.0) | .020 |
| Lysholm (0 to 100) | 88.2 ± 11.8 (53.0 to 100.0) | 93.7 ± 8.1 (65.0 to 100.0) | .008 |
| Tegner (0 to 10) | 7.1 ± 1.9 (4 to 10) | 7.5 ± 1.6 (4 to 10) | .358 |
| ACL-RSI (0 to 100) | 67.1 ± 25.1 (19.2 to 100.0) | 74.8 ± 22.7 (18.3 to 100.0) | .218 |
| Global rating of change scale (–5 to 5) | 3.0 ± 1.8 (–2 to 5) | 4.0 ± 1.1 (–1 to 5) | .001 |
aData are shown as mean ± SD (range). Bolded P values indicate statistically significant differences between 1- and 2-year follow-up (P < .05). ACL-RSI, Anterior Cruciate Ligament–Return to Sport after Injury; ADL, Activities of Daily Living; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; KOS, Knee Outcome Survey.